rAd26-S
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for rAd26-S, covering 2022-06-03 to 2022-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19) [Phase 1, Phase 2]